BIOLOGY42 GENERATIVE BIOLOGICS
LIVE

Serial Number

98645490

Owner

Insilico Medicine IP Limited

Attorney

Jacqueline M. Lesser

Filing Date

Jul 12, 2024

Add to watchlist:

No watchlists yet
View on USPTO

BIOLOGY42 GENERATIVE BIOLOGICS Trademark

Serial Number: 98645490

BIOLOGY42 GENERATIVE BIOLOGICS is a trademark filed by Insilico Medicine IP Limited on July 12, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Insilico Medicine IP Limited (20 trademarks)

Three Exchange Square, 8 Connaught Place
Central , HK

Entity Type: 77

Trademark Details

Filing Date

July 12, 2024

Registration Date

Not Registered

Goods & Services

Computer software design; software as a service (SAAS) services featuring software for using artificial intelligence for automated machine learning in the field of biologics design and development, in particular, peptides, nanobodies, and antibodies tailored for specific targets; software development in the framework of software publishing; platform as a service (PAAS) featuring computer software platforms for using artificial intelligence for automated machine learning in the field of biologics design and development, in particular, peptides, nanobodies, and antibodies tailored for specific targets; development of computer platforms; computer system design; rental of computer software using artificial intelligence for automated machine learning in the field of biologics design and development; creating and designing website based indexes of data and information for others using information technology; computer programming services; maintenance of computer software; research and development of new products for others; scientific and technological research relating to patent mapping; scientific research; installation of computer software; installation, maintenance, and updating of computer software; installation of software using artificial intelligence for automated machine learning in the field of biologics design and development, in particular, peptides, nanobodies, and antibodies tailored for specific targets; customizing computer software; custom design of computer software; developing customized software for others in the field of biologics design and development, in particular, peptides, nanobodies, and antibodies tailored for specific targets

Downloadable and recorded computer software platforms using artificial intelligence for automated machine learning in the field of biologics design and development; computer operating programs, recorded; data processing apparatus

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 15, 2026 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 27, 2026 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 1, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 1, 2025 GNSL
SUSPENSION LETTER WRITTEN
Oct 1, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 11, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 11, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 11, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 24, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 24, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 11, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 11, 2025 GNRT
NON-FINAL ACTION WRITTEN
Feb 11, 2025 CNRT
ASSIGNED TO EXAMINER
Feb 4, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 3, 2025 NWOS
NEW APPLICATION ENTERED
Jul 12, 2024 NWAP